Rescue Biomedical (IMAGE)
Caption
Rescue Biomedical is developing a minimally invasive subcutaneous device that automatically delivers naloxone when a person overdoses on an opioid. The company has received a four-year, $2.82 million Fast-Track Small Business Innovation Research, or SBIR, grant from the National Institutes of Health to develop its technology.
Credit
Photo courtesy Hugh Lee.
Usage Restrictions
None
License
Original content